Gevo, Inc. (NASDAQ:GEVO) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday. The firm currently has a $0.75 price target on the energy company’s stock. Zacks Investment Research‘s target price indicates a potential upside of 17.10% from the company’s previous close.

According to Zacks, “Gevo, Inc. is a renewable chemicals and advanced biofuels company engaged in the development of biobased alternatives to petroleum-based products using a combination of synthetic biology and chemistry. The Company is focused on the commercialization of isobutanol, a naturally occurring four carbon alcohol with broad applications in large chemicals and fuels markets. Isobutanol can be used as a solvent and a gasoline blendstock and can be further processed into jet fuel and feedstocks for the production of synthetic rubber, plastics and polyesters. Markets served by the Company include solvents and coatings, materials, plastics and fibers, biojet blendstock, gasoline blendstock and other hydrocarbon fuels. “

GEVO has been the subject of a number of other research reports. Rodman & Renshaw reissued a “buy” rating and issued a $12.00 target price on shares of Gevo in a research report on Wednesday, August 9th. HC Wainwright set a $12.00 target price on shares of Gevo and gave the company a “buy” rating in a research report on Friday, August 4th.

Shares of Gevo (GEVO) opened at 0.6405 on Tuesday. The stock has a 50 day moving average of $0.61 and a 200-day moving average of $0.91. The firm’s market cap is $10.38 million. Gevo has a 52 week low of $0.53 and a 52 week high of $15.97.

Gevo (NASDAQ:GEVO) last announced its earnings results on Thursday, August 3rd. The energy company reported ($0.44) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.54) by $0.10. The company had revenue of $7.54 million during the quarter, compared to analysts’ expectations of $5.63 million. Gevo had a negative net margin of 108.84% and a negative return on equity of 43.79%. Equities research analysts expect that Gevo will post ($2.94) earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Gevo, Inc. (GEVO) Stock Rating Upgraded by Zacks Investment Research” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another site, it was stolen and reposted in violation of US & international copyright law. The legal version of this report can be accessed at https://www.thecerbatgem.com/2017/08/31/gevo-inc-gevo-stock-rating-upgraded-by-zacks-investment-research.html.

A number of large investors have recently bought and sold shares of the company. Sabby Management LLC purchased a new stake in Gevo during the first quarter valued at $1,274,000. Virtu KCG Holdings LLC boosted its stake in Gevo by 557.6% in the second quarter. Virtu KCG Holdings LLC now owns 182,390 shares of the energy company’s stock valued at $126,000 after buying an additional 154,654 shares in the last quarter. Finally, Vanguard Group Inc. boosted its stake in Gevo by 22.4% in the second quarter. Vanguard Group Inc. now owns 486,959 shares of the energy company’s stock valued at $336,000 after buying an additional 89,020 shares in the last quarter. 13.14% of the stock is owned by institutional investors and hedge funds.

About Gevo

Gevo, Inc (Gevo) is a renewable chemicals and next generation biofuels company. The Company has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock.

Receive News & Stock Ratings for Gevo Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo Inc. and related stocks with our FREE daily email newsletter.